Results 101 to 110 of about 9,598 (127)

Treatment Options for Metallo-Beta-Lactamase-Producing <i>Enterobacterales</i> in the Era of Increasing Resistance. [PDF]

Int J Mol Sci
Golovina A, Antipin F, Khalymbadzha I, Terina O, Yakovlev D, Fedina E, Ivanov R.   +6 more
europepmc   +1 more source

The shift from "MIC-Only" back to carbapenemase testing among carbapenem-resistant Enterobacterales: what clinical laboratories need to know about updated CLSI guidance. [PDF]

J Clin Microbiol
Simner PJ.
europepmc   +1 more source

<i>In vitro</i> activity of aztreonam-avibactam and comparators against <i>Enterobacterales</i> isolated from bloodstream infections: ATLAS/ surveillance, 2021-2022. [PDF]

Microbiol Spectr
Rossolini GM, Hu F, Sethuraman N, Kamat S, Mohamed N, Stone G, Perez KK.   +6 more
europepmc   +1 more source

Evaluation of BD Phoenix CPO Detect and NG-Test CARBA 5 for the detection and classification of carbapenemase-producing <i>Enterobacterales</i> using whole-genome sequencing as the reference standard. [PDF]

Microbiol Spectr
Aji N, Thomas N, Pérez-López A, Suleiman M.   +3 more
europepmc   +1 more source

Carbapenem-resistant Gram-negative pathogens: molecular epidemiology, diagnostic advances, and emerging therapeutic strategies. [PDF]

Front Microbiol
Khan M, Patil P, Rathored J.
europepmc   +1 more source

Carbapenemase Detection Methods in Clinical Microbiology: Conventional and Automated Approaches. [PDF]

Cureus
Dhavale SL, Patil HV, Patil SR.
europepmc   +1 more source

Application of metagenomic next-generation sequencing as an adjunct to conventional microbiological testing for the diagnosis of infection in kidney transplant recipients. [PDF]

Front Cell Infect Microbiol
Vuth H, Wang W, Qin W, Yang M, Li Y, Zhou Q, Xu X, Zhang J, Zhao H.   +8 more
europepmc   +1 more source

Cefepime 2.0: Upgrading β-Lactamase Inhibitor Use. [PDF]

Microorganisms
De Rosa FG, Lupia T, Fornari V, Vita D, Casarotto M, Corcione S, Oliva A.   +6 more
europepmc   +1 more source